摘要
心血管疾病(CVD)是导致男性和女性死亡的主要原因。与男性相比,常见的传统危险因素CVD,如高胆固醇血症,高血压和吸烟具有 高患病率在一些情况下影响妇女会更大。然而,风险因素较少和较少攻击女性,部分原因是公众健康的制造者,患者和医生对其意识减 少。大约75%的妇女的冠状动脉心脏疾病死亡可避免,如果像高胆固醇血症,高血压和吸烟心血管病危险因素得到充分的治疗。这篇叙 事综述了4心血管疾病的危险因素,即高胆固醇血症,高血压,吸烟和糖尿病的治疗。在弗雷明汉心脏研究多年后,这些风险因素被发现 在心脏病研究中,这四种是心血管疾病的发展最重要的危险因素。
关键词: 心血管疾病,糖尿病,性别,高胆固醇,高血压,吸烟
Current Medicinal Chemistry
Title:Treatment of Cardiovascular Risk Factors in Women
Volume: 22 Issue: 31
Author(s): I. Gouni-Berthold and H. K. Berthold
Affiliation:
关键词: 心血管疾病,糖尿病,性别,高胆固醇,高血压,吸烟
摘要: Cardiovascular disease (CVD) is a leading cause of death for both women and men. Common traditional risk factors for CVD, such as hypercholesterolemia, hypertension and smoking have a high prevalence in women and in some cases a greater health impact compared with men. Nevertheless, risk factors are treated less often and less aggressively in women than in men, partly due to decreased awareness on the part of public health opinion makers, patients and physicians. About seventy five percent of all coronary heart disease deaths among women could be avoided if CVD risk factors like hypercholesterolemia, hypertension and smoking are adequately treated. This narrative review discusses the treatment of the 4 CVD risk factors, namely hypercholesterolemia, hypertension, smoking and diabetes. These risk factors were examined in the Framingham Heart study and years later they were found in the INTERHEART study to be the 4 most important risk factors for the development of CVD.
Export Options
About this article
Cite this article as:
I. Gouni-Berthold and H. K. Berthold , Treatment of Cardiovascular Risk Factors in Women, Current Medicinal Chemistry 2015; 22 (31) . https://dx.doi.org/10.2174/0929867322666151001122213
DOI https://dx.doi.org/10.2174/0929867322666151001122213 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Killing of Human Neuroblastoma Cells by the Small Molecule JQ1 Occurs in a p53-Dependent Manner
Anti-Cancer Agents in Medicinal Chemistry Cytoprotection by Natural and Synthetic Polyphenols in the Heart: Novel Mechanisms and Perspectives
Current Pharmaceutical Design How to Recognize Epicardial Origin of Ventricular Tachycardias?
Current Cardiology Reviews Statins in the Treatment of Acute Ischemic Stroke
Current Pharmaceutical Biotechnology Non-Communicable Diseases and Adherence to Mediterranean Diet
Endocrine, Metabolic & Immune Disorders - Drug Targets The Use of Exercise Echocardiography in the Evaluation of Mitral Regurgitation
Current Cardiology Reviews Resveratrol Targets in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Effects of School-Based Physical Activity Interventions on Cognition and Academic Achievement: A Systematic Review
CNS & Neurological Disorders - Drug Targets Fluoroquinolones: Blessings Or Curses
Current Drug Targets Passive Smoking and Coronary Heart Disease
Current Vascular Pharmacology Melatonin in Cardiac Ischemia/Reperfusion-Induced Mitochondrial Adaptive Changes
Cardiovascular & Hematological Disorders-Drug Targets Dietary Factors Influencing Magnesium Absorption in Humans
Current Nutrition & Food Science A Single Pill to Treat Postmenopausal Hypertension? Not Yet
Current Topics in Medicinal Chemistry Management of Incidental Findings in the Era of Next-generation Sequencing
Current Genomics Establishing Genomic/Transcriptomic Links Between Alzheimer’s Disease and Type 2 Diabetes Mellitus by Meta-Analysis Approach
CNS & Neurological Disorders - Drug Targets Levosimendan: A New Inodilatory Drug for the Treatment of Decompensated Heart Failure
Current Pharmaceutical Design Neuropharmacological Aspects of Crocus sativus L.: A Review of Preclinical Studies and Ongoing Clinical Research
CNS & Neurological Disorders - Drug Targets Novel Antidepressant Drugs, Arterial Hypertension and Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Novel Ligands: Fine Tuning the Transcriptional Activity of the Glucocorticoid Receptor
Current Pharmaceutical Design Chromogranins and Inositol 1,4,5-Trisphosphate-Dependent Ca2+-Signaling in Cardiomyopathy and Heart Failure
Current Medicinal Chemistry